Cargando…

Human Wharton’s Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses

Human SARS-CoV-2 and avian infectious bronchitis virus (IBV) are highly contagious and deadly coronaviruses, causing devastating respiratory diseases in humans and chickens. The lack of effective therapeutics exacerbates the impact of outbreaks associated with SARS-CoV-2 and IBV infections. Thus, no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussein, Mohamed A. A., Hussein, Hosni A. M., Thabet, Ali A., Selim, Karim M., Dawood, Mervat A., El-Adly, Ahmed M., Wardany, Ahmed A., Sobhy, Ali, Magdeldin, Sameh, Osama, Aya, Anwar, Ali M., Abdel-Wahab, Mohammed, Askar, Hussam, Bakhiet, Elsayed K., Sultan, Serageldeen, Ezzat, Amgad A., Abdel Raouf, Usama, Afifi, Magdy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101656/ https://www.ncbi.nlm.nih.gov/pubmed/35563714 http://dx.doi.org/10.3390/cells11091408

Ejemplares similares

Phenotypical changes of hematopoietic stem and progenitor cells in COVID-19 patients: Correlation with disease status
por: Hussein, Hosni A. M., et al.
Publicado: (2023)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

Memory T Cells Discrepancies in COVID-19 Patients
por: Al Saihati, Hajir A., et al.
Publicado: (2023)

Decellularization of Wharton’s Jelly Increases Its Bioactivity and Antibacterial Properties
por: Dubus, M., et al.
Publicado: (2022)

Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
por: Talebi, Mehdi, et al.
Publicado: (2020)

Cytokines secreted by human Wharton's jelly stem cells inhibit the proliferation of ovarian cancer (OVCAR3) cells in vitro
por: Kalamegam, Gauthaman, et al.
Publicado: (2019)

Wharton’s jelly absence: a possible cause of stillbirth
por: Damasceno, Eduarda Bittencourt, et al.
Publicado: (2013)

Antibacterial and Immunomodulatory Properties of Acellular Wharton’s Jelly Matrix
por: Dubus, Marie, et al.
Publicado: (2022)

Osteogenic differentiation of mesenchymal stem cells cultured on PLLA scaffold coated with Wharton's Jelly
por: Ahmadi, Marziehsadat, et al.
Publicado: (2017)

Beyond RGD: virus interactions with integrins
por: Hussein, Hosni A. M., et al.
Publicado: (2015)

Possible Underlying Mechanisms for the Renoprotective Effect of Retinoic Acid-Pretreated Wharton’s Jelly Mesenchymal Stem Cells against Renal Ischemia/Reperfusion Injury
por: Barakat, Mai, et al.
Publicado: (2022)

Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014)

Effect of type 2 diabetic serum on the behavior of Wharton's jelly-derived mesenchymal stem cells in vitro
por: Ali, Fatima, et al.
Publicado: (2017)

Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
por: Kamal, Mohamed M., et al.
Publicado: (2020)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
por: Gupta, Ashim, et al.
Publicado: (2020)

Cardioprotective Effects of Wharton Jelly Derived Mesenchymal Stem Cell Transplantation in a Rodent Model of Myocardial Injury
por: Gaafar, Taghrid, et al.
Publicado: (2017)

Wharton's Jelly human Mesenchymal Stem Cell contact guidance by noisy nanotopographies
por: Jacchetti, E., et al.
Publicado: (2014)

The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease model
por: El Miniawy, Hala M. F., et al.
Publicado: (2022)

Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Silicon–Gold Nanoparticles Affect Wharton’s Jelly Phenotype and Secretome during Tri-Lineage Differentiation
por: Svirshchevskaya, Elena V., et al.
Publicado: (2022)

Umbilical Cord-Derived Wharton’s Jelly for Regenerative Medicine Applications: A Systematic Review
por: Main, Benjamin J., et al.
Publicado: (2021)

Proteome analysis of human Wharton's jelly cells during in vitro expansion
por: Angelucci, Stefania, et al.
Publicado: (2010)

Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)

Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011)

Abstract 126: Wharton’s Jelly Induces Osteogenesis In An Alveolar Cleft Model
por: Greives, Matthew R., et al.
Publicado: (2017)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)

The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton’s Jelly Stem Cells
por: Ma, Li, et al.
Publicado: (2023)

Mechanisms of Wharton’s Jelly-derived MSCs in enhancing peripheral nerve regeneration
por: Shin, Young Ho, et al.
Publicado: (2023)

Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis
por: Hammam, Olfat A., et al.
Publicado: (2016)

The RYR3 gene is involved in Wharton’s jelly derived mesenchymal stem cell treatment of Alzheimer’s disease in rats
por: Ali, Hirowati, et al.
Publicado: (2023)

Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome?
por: Teixeira, Fábio G., et al.
Publicado: (2015)

Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up()
por: Saleh, Mahshid, et al.
Publicado: (2022)

Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration
por: Leow, S. N., et al.
Publicado: (2015)

Wharton’s Jelly–Mesenchymal Stem Cell–Engineered Conduit for Pulmonary Artery Reconstruction in Growing Piglets
por: Rapetto, Filippo, et al.
Publicado: (2022)

Corrigendum: Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis
por: Hammam, Olfat A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rduhjsdpvhpirlglfr79tnnjj5